Low-Dose Radiotherapy With Retlirafusp Alfa and Chemotherapy as Neoadjuvant Therapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Clinical trial NCT07682376 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT07682376

Sponsor

Harbin Medical University

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2026-06-10

Primary completion

2028-05-30

Enrollment

96

View on ClinicalTrials.gov